(Chicago, IL, Monday, June 4, 2018) - The latest in clinical cancer research, from new treatment options and advances in precision medicine to insights for improving access to care, will be highlighted at the 54th Annual Meeting of the American Society of Clinical Oncology (ASCO).
The 2018 ASCO Annual Meeting, taking place June 1-5 in Chicago, will bring together more than 32,000 oncology professionals from around the world. The theme of this yearâ€™s conference is Delivering Discoveries: Expanding the Reach of Precision Medicine.
Research to be released at the meeting will shed light on:
- Whether some women with breast cancer may forgo chemotherapy;
- The long-standing notion that black men with prostate cancer have worse health outcomes than white men;
- Ways to increase the quality and frequency of communication with older patients with cancer;
- If a blood test can be used to detect early-stage lung cancer; and
- Treatment disparities in men and women with head and neck cancer.
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO) is committed to making a world of difference in cancer care. As the worldâ€™s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net.